2018-19 Section 7-Neoplastic and Inflammatory Diseases of the Head and Neck eBook
Research Original Investigation
Epidemiology and Treatment of Malignant Submandibular Gland Tumors
Figure. Overall and Disease-Specific Survival of Patients With Submandibular Gland Tumor Using Kaplan-Meier Analysis
Overall survival for entire cohort A
Disease-specific survival for entire cohort B
1.0
1.0
0.8
0.8
0.6
0.6
0.4 Survival
0.4 Survival
0.2
0.2
0
0
0
100
200 300 400
500
0
100
200 300 400
500
Time, mo
Time, mo
No. at risk
No. at risk
2622
712
217
75
23
2182
638
202
71
23
Overall survival stratified by stage at presentation C
Disease-specific survival stratified by stage at presentation D
Stage I Stage II Stage III Stage IV
1.0
1.0
Stage I Stage II Stage III Stage IV
0.8
0.8
0.6
0.6
0.4 Survival
0.4 Survival
0.2
0.2
0
0
0
100
200 300 400
500
0
100
200 300 400
500
Time, mo
Time, mo
No. at risk Stage I
No. at risk Stage I
435 293 420 528
136
31 21 21
4 3 7 1
0 0 0 0
370 247 332 430
123
20 20 20
3 3 5 1
0 0 0 0
Stage II Stage III Stage IV
Stage II Stage III Stage IV
83
73 98 39
108
46
5
4
Overall survival stratified by histologic subtype E
Disease-specific survival stratified by histologic subtype F
1.0
1.0
Squamous cell carcinoma Adenocarcinoma Adenoid cystic carcinoma Mucoepidermoid carcinoma
Squamous cell carcinoma Adenocarcinoma Adenoid cystic carcinoma Mucoepidermoid carcinoma
0.8
0.8
0.6
0.6
0.4 Survival
0.4 Survival
0.2
0.2
0
0
0
100
200 300 400
500
0
100
200 300 400
500
Time, mo
Time, mo
No. at risk Squamous cell carcinoma Adenocarcinoma Adenoid cystic carcinoma Mucoepidermoid carcinoma
No. at risk Squamous cell carcinoma Adenocarcinoma Adenoid cystic carcinoma Mucoepidermoid carcinoma
475 360 945 443
53 81
8
1 6
0 1
357 289 833 373
45 72
7
1 6
0 1
20
19
346 133
124
51 12
19
319 113
118
48 12
19
41
1
35
1
JAMA Otolaryngology–Head & Neck Surgery October 2015 Volume 141, Number 10 (Reprinted)
jamaotolaryngology.com
Copyright 2015 American Medical Association. All rights reserved.
21
Made with FlippingBook Annual report